Latest Breaking News On - Bright minds biosciences - Page 3 : comparemela.com

Short Interest in Bright Minds Biosciences Inc (NASDAQ:DRUG) Declines By 5 6%

Short Interest in Bright Minds Biosciences Inc (NASDAQ:DRUG) Declines By 5 6%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Advisorshares investmentsVirtu financialBright minds biosciences incBright minds biosciencesGet free reportMinds biosciencesBright mindsStreet groupShares investmentsMinds biosciences incBright minds biosciences daily

Bright Minds Biosciences Inc (NASDAQ:DRUG) Short Interest Up 21 6% in November

Bright Minds Biosciences Inc (NASDAQ:DRUG) Short Interest Up 21 6% in November
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Bright minds biosciences incVirtu financialBright minds biosciences company profileAdvisorshares investmentsBright minds biosciencesGet free reportMinds biosciencesBright mindsStreet groupShares investmentsMinds biosciences incBright minds biosciences daily

PurMinds NeuroPharma: PurMinds Appoints Leading Drug Designer, Dr Alan Kozikowski, to Chief Scientific Officer and Appoints Pharma Veteran Dr Max Arella to Scientific Advisory Board

PurMinds NeuroPharma: PurMinds Appoints Leading Drug Designer, Dr Alan Kozikowski, to Chief Scientific Officer and Appoints Pharma Veteran Dr Max Arella to Scientific Advisory Board
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAlan kozikowskiKristina spionjackJanet qiPurminds neuropharmaAmy reicheltArmand frappier university du quebecMassachusetts newsfile corpVirology research centreCompany scientific advisory boardHealth canada controlled drugsMinds neuropharmaProfessor alan kozikowskiChief scientific officerProfessor max arellaScientific advisory board

PurMinds NeuroPharma: PurMinds Appoints Leading Drug Designer, Dr Alan Kozikowski to the Scientific Advisory Board

PurMinds NeuroPharma: PurMinds Appoints Leading Drug Designer, Dr Alan Kozikowski to the Scientific Advisory Board
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergKristina spionjackPurminds neuropharmaAlan kozikowskiJanet qiCompany scientific advisory boardNewsfile corpStarwise therapeuticHealth canadaMinds neuropharmaProfessor alan kozikowskiScientific advisory boardNovel chemical entitiesBright minds biosciencesPurmind chief executive officerControlled substances

Comparing Bright Minds Biosciences (NASDAQ:DRUG) & Cardio Diagnostics (NASDAQ:CDIO)

Bright Minds Biosciences (NASDAQ:DRUG – Get Free Report) and Cardio Diagnostics (NASDAQ:CDIO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, profitability and analyst recommendations. Profitability This table compares Bright Minds […]

United statesNew yorkUniversity of texas medical branchBright minds biosciences incCollege of wisconsinNational institutes of healthCardio diagnostics holdings incBright minds biosciencesGet free reportCardio diagnosticsCardio diagnosticMinds biosciencesBright mindsGiven cardio diagnosticMinds biosciences incNational institutes